Browse

You are looking at 501 - 550 of 1,314 items for :

  • Clinical Resources x
  • Refine by Access: All content x
Clear All
Restricted access

Pyrazinamide Suspension 100 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Pyrazinamide Syrup 100 mg/mL*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Pyridoxine Hydrochloride Suspension 50 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Pyrimethamine Suspension 2 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Pyrimethamine Suspension 2 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Quinapril Syrup 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Quinidine Sulfate Suspension 10 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Quinidine Sulfate Suspension 10 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Free access

1 RATIONAL USE OF DRUG CONCENTRATION MEASUREMENTS

John E. Murphy

Restricted access

CH 1.4 Renal Drug Dosing

John E. Murphy

Restricted access

CH 2.4 Renal Drug Dosing

John E. Murphy

Restricted access

3 RENAL DRUG DOSING CONCEPTS

Dean A. Van Loo and Thomas C. Dowling

Restricted access

10 Renal Function and Related Tests

Kimmy T. Nguyen

Restricted access

20 Rheumatic Diseases

Susan P. Bruce

Restricted access

Riboflavin Suspension 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Rifabutin Suspension 20 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Rifampin Suspension 25 mg/mL—Formulation 1*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Rifampin Suspension 25 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Rifampin Syrup 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Rifaximin Suspension 20 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Rosuvastatin Suspension 4 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Rufinamide Suspension 40 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Sertraline Hydrochloride Suspension 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Sildenafil Citrate Suspension 2.5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Simvastatin Suspension 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Sodium Benzoate Syrup 250 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Sodium Phenylbutyrate Suspension 200 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Solution/Suspension/Syrup

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Sotalol Hydrochloride Suspension 5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

SECTION 2: Specific Drugs and Drug Classes

John E. Murphy

Restricted access

Spironolactone 5 mg/mL and Hydrochlorothiazide 5 mg/mL Suspension—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Spironolactone 5 mg/mL and Hydrochlorothiazide 5 mg/mL Suspension—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Spironolactone Suspension 2.5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Spironolactone Suspension 2 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Spironolactone Suspension 25 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Spironolactone Suspension 25 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Spironolactone Suspension 26 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Spironolactone Syrup 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Spironolactone Syrup 2.5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Spironolactone Syrup 5 mg/mL*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Sulfadiazine Suspension 100 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Sulfasalazine Suspension 100 mg/mL—Formulation 1

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Sulfasalazine Suspension 100 mg/mL—Formulation 2

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Sumatriptan Succinate Suspension 5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Sunitinib Malate Suspension 10 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

PART II SYSTEM DISORDERS AND DIAGNOSTIC TESTS

Christopher J. Edwards and Brian L. Erstad

Restricted access

Tacrolimus Monohydrate Suspension 0.5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Tacrolimus Monohydrate Suspension 1 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Tacrolimus Suspension 0.5 mg/mL

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes

Restricted access

Tacrolimus Suspension 1 mg/mL*

Rita K. Jew, Winson Soo-Hoo, Elham Amiri, and Jamie M. Gomes